The Patent Finder
US

NPP1 Fusion Proteins

US 9,540,621 In force, term unresolved
OverviewFamilyAssignmentsSources & methods

Also listed on Inozyme Pharma, Inc., an earlier holder on the record. The recorded assignments below show how it moved.

Collateral for a security interest recorded Apr 27, 2026 (Citibank, N.A.).

Term ends no later than Mar 11, 2031 · Medium confidence

In force on USPTO's status record and by its fee record. A terminal disclaimer on file may shorten this term, possibly to a date already past; its reference document is unresolved, so the date above is an upper bound and no earlier date is guessed.

Filed Aug 1, 2014 as application 14/449,364 · Granted Jan 10, 2017
Base term, 20 years from filing
Today
20 years from filing
2011 2031
Clock starts
Mar 11, 2011
Ends no later than
Mar 11, 2031
Granted
Jan 10, 2017
base term fee events Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
Unresolved
Terminal disclaimer
On file, reference document not resolved, so the date above is an upper bound. We do not guess the cap.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
9
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. 2 of 3 maintenance fees are paid so far. Confidence: Medium. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Mar 11, 2011, when application PCT/US2011/028233, the earliest non-provisional in its chain, was filed (this one was filed Aug 1, 2014)Mar 11, 2031High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer on file (approved), reference document not resolvedno cap applied, and none guessedMedium confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events2 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderno later than Mar 11, 2031Medium confidence

This family

Application PCT/US2011/028233PCT application
no patent term
no patent term
US 8,846,603In force
Mar 2031
Mar 2031
Application 14/004,294Abandoned
not computed
not computed
US 9,540,621this patent
no later than Mar 2031
no later than Mar 2031
Application 15/417,590Abandoned
not computed
not computed
Application 17/105,245Abandoned
not computed
not computed
Application 17/819,065Abandoned
not computed
not computed
Application 19/183,431Pending
not computed
not computed
8 of 9 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Nov 15, 2016
Reel 40329, frame 154
Synageva Biopharma Corp.; Galaxy Merger Sub LLCAlexion Pharma LLCMerger and Change of Name
Nov 17, 2016
Reel 40361, frame 470
Alexion Pharma LLCAlexion Pharmaceuticals, Inc.Assignment of Assignor's Interest
Nov 23, 2020
Reel 54449, frame 251
Alexion Pharmaceuticals, Inc.Inozyme Pharma, Inc.Assignment of Assignor's Interest
Aug 9, 2021
Reel 57127, frame 791
Alexion Pharma LLCAlexion Pharmaceuticals, Inc.Corrective Assignment to Correct the Execution Date of the Assignment Previously Recorded at Reel: 040361 Frame: 0470. Assignor(S) Hereby Confirms the Assignment.
Nov 25, 2025
Reel 73707, frame 488
Inozyme Pharma, Inc.Biomarin Pharmaceutical Inc.Assignment of Assignor's Interest
Apr 27, 2026
Reel 75493, frame 968
Biomarin Pharmaceutical Inc.; Amicus Therapeutics, Inc.Citibank, N.A., as Collateral AgentSecurity Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited